Effects of cytoflavin and neuronol on morphological changes in the brain and survival of rats with ischemic disturbances in cerebral blood flow.
Bul'on
V V
VV
Department of Neuropharmacology; Institute of Experimental Medicine, Russian Academy of Medical Sciences; Scientific Technological Pharmaceutical Company Polysan, St. Petersburg. sns@iem.spb.ru
Krylova
I B
IB
Evdokimova
N R
NR
Kovalenko
A L
AL
Alekseeva
L E
LE
Sapronov
N S
NS
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000473:pathology; D002545:Brain Ischemia / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D002560:Cerebrovascular Circulation; D004338:Drug Combinations; D005486:Flavin Mononucleotide / Q000494:pharmacology*; D007290:Inosine Diphosphate / Q000494:pharmacology*; D008297:Male; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009536:Niacinamide / Q000494:pharmacology*; D051381:Rats; D012039:Regional Blood Flow; D015427:Reperfusion Injury / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control; D013386:Succinates / Q000494:pharmacology*; D019802:Succinic Acid / Q000494:pharmacology*; D015996:Survival Rate
D004338:Drug Combinations; C493850:Neuronol; D018696:Neuroprotective Agents; D013386:Succinates; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate; D019802:Succinic Acid